Available PK Models in WAPPS-Hemo

Factor	Model	Assay	Number of Patient in the derivation (% of WAPPS-Hemo)	No. Samples Median [Min Max]
VIII	Advate	CH	91 (100%)
VIII	Adynovate	OS	101 (100%)	3 [1-6]
VIII	Adynovate	CH	53 (100%)	4 [1-5]
VIII	Afstyla	OS	130	9 [4-12]
VIII	Afstyla	CH	130	9 [4-12]
VIII	Alphanate/Fanhdi	OS	92 (100%)	4 [1-7]
VIII	Elocta/Eloctate	OS	164	4 [3-7]
VIII	Elocta/Eloctate	CH	164	4 [3-7]
VIII	Jivi	OS	145	1 [1-11]
VIII	Jivi	CH	145	1 [1-11]
VIII	Kovaltry	OS	293 (56%)	1 [1-10]
VIII	Kovaltry	CH	183	1 [1-10]
VIII	Nuwiq	OS	114 (100%)	9 [6-11]
VIII	Nuwiq	CH	113 (100%)	9 [6-11]
VIII	Octanate	OS	44 (100%)	9 [3-10]
VIII	Octanate	CH	44 (100%)	9 [3-10]
VIII	Refacto AF/Xyntha	OS	171 (81%)	3 [1-10]
IX	Alprolix	OS	304 (60%)	6 [1-13]
IX	Generic for FIX:	OS	124 (60%)	9 [1-17]
IX	Plasma Derived²	OS	124 (60%)	9 [1-17]
IX	Generic for FIX:	OS	99 (39%)	8 [1-13]
IX	Recombinant³	OS	99 (39%)	8 [1-13]
IX	Idelvion	OS	106	9 [3-12]
IX	Rebynin	OS	89	1 [1-14]